PRS-343 in HER2-Positive Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Margetuximab Expanded Access Program
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
Fasting on Newly Diagnosed Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Hormonal Therapy Combined With Chemoimmunotherapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Patients With Brain Metastases From HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
- Status
- TERMINATED
- Phase
- PHASE1
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Eribulin Mesylate, Trastuzumab, and Pertuzumab in Women With Metastatic, Unresectable Locally Advanced, or Locally Recurrent HER2-Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2